Consent

Cookies are small files that are saved on your device. Some of these cookies are essential, while other cookies help us to improve your experience by providing insights into how the site is being used.

For more detailed information, please see our cookie policy

Skip to content

Local Health and Global Profits

Background

One of the influences on health that remains poorly understood at local level is the commercial sector, despite growing evidence of its major impacts on health and equity. While local businesses create jobs and contribute to the economy and health in positive ways, certain commercial actors have a disproportionate impact on population health.

Approximately 40% of chronic disease deaths globally are directly linked to just four products manufactured by transnational corporations manufacturing: tobacco, ultra-processed foods, alcohol and fossil fuels.

In parallel, representatives of these sectors frequently oppose interventions that local governments could implement.

Our partners and approach

Local Health and Global Profits brings together researchers at the Universities of Bath, Cambridge, Edinburgh, Sheffield and the London School of Hygiene and Tropical Medicine.

They are working with local governments, local populations and public health practitioners, including the Association of Directors of Public Health and civil society groups.

Together, they aim to understand the building blocks, including the commercial factors, that impact on communities’ health.

Taking a systems approach, it will use that knowledge to identify, implement and evaluate the population-level interventions most likely to improve health, wellbeing and equity at scale. It will also work specifically to explore and address the barriers to implementing interventions.

Aims and objectives

The overall aim of the programme is to take an integrated systems approach, in order to

  1. identify potential actions (diverse forms of interventions) to address the upstream determinants of health and the facilitators and barriers to implementing these actions

  2. develop and implement resources and support systems, to better enable local authorities to implement these actions

  3. take a comprehensive approach to assessing the health and economic impacts of these interventions and disseminate the selected interventions and supporting tools.

Objectives

Operating at local level, the primary objectives of this research consortium are to:

  • use an integrated systems approach to better understand, identify and prioritise potential areas of action to address upstream (commercial and interlinked social, political and economic) determinants of health

  • critically examine evidence for actions that can address upstream (commercial) determinants of health, categorising them to help identify those that require minimum agency, can promote health and equity at scale and act on system levers

  • explore facilitators and barriers to the effective implementation of such actions and how these can most effectively be addressed

  • co-develop appropriate resources (tools and training), support systems and locally relevant evidence that will enable local actors to overcome these barriers

  • comprehensively assess the anticipated health and economic impacts of actions and whether changing the paradigm of the impact assessment approach (for example changing the underlying economic model) changes their measured effectiveness and how they are perceived and prioritised by policy-makers

  • compile novel large scale data resources for use at local level to enable this

  • enable implementation of actions, including policy change, by providing appropriate support systems

  • undertake complex systems evaluations of the selected actions, resources and support systems

  • scale up and exchange knowledge to promote equitable population health improvement.

Work packages

Systems approaches to commercial determinants of health and equity: project design

A visual representation of Work Packages (WPs) as detailed in then following text.
  • WP1: Identifying System Structures and Levers.

  • WP2: Actions: identifying, evaluating and categorising options for Local Authorities to address upstream Commercial Determinants of Health.

  • WP3: Understanding facilitators and barriers to upstream action and developing resources to address barriers.

  • WP4: Develop and implement tools to assess health, economic and inequality impacts of actions.

  • WP5: Implementation.

  • WP6: Evaluation.

  • WP7: Knowledge exchange and scale-up.

A portrait of Professor Anna Gilmore.

Anna Gilmore is Professor of Public Health, Director of the Tobacco Control Research Group and Co-Director Centre for 21st Century Public Health at the University of Bath. She is a public health physician, with an MSc (dist) and PhD in Public Health from LSHTM, is a Fellow of the Faculty of Public Health & holds an honorary clinic contract with Office of Health Improvement and Disparities. She is a global leader in research on the commercial determinants of health, particularly in relation to the tobacco industry.

A portrait of Professor Eleonora Fichera.

Eleonora is Professor of Applied Economics. She joined the Department of Economics in March 2017 as Senior Lecturer. She was Acting Head of the Economics Department in 2022-2023, Deputy Head of Department between 2019-2022 and became Reader in 2019. Since January 2022 she is co-Editor of Health Economics, including its Letters section. Previously, she was working at the Manchester Centre for Health Economics, University of Manchester where she held an MRC Early Career Fellowship in Economics of Health (2013-2016). Eleonora's research interests are in the economics of health and applied micro-econometrics.

A portrait of Dr Nason Maani.

Nason's research interests centre on the structural and commercial determinants of health, with a special interest in how they shape public understanding and policy. This includes primary research on the alcohol, sugar sweetened beverage, firearm, social media, and fossil fuel industries, as well as policy research on the relationships between underinvestment, commercial influence and inequity. He also communicates research to wider audiences though various media, including hosting Money Power Health, a podcast on the commercial drivers of ill health.

Meet the team

Read more...

WP 1: Identifying System Structures and Levers

WP 2: "Actions": identifying, evaluating and categorising options for LAs to address upstream CDOH

WP 3: Understanding facilitators and barriers to upstream action and developing resources to address barriers 

WP 4: Develop and implement tools to assess health, economic and inequality impacts of actions

WP 5: Implementation

WP 6: Evaluation

WP 7: Knowledge exchange (KE) and scale up

Operational support team

  • Cheryl Routley, Consortium Manager, University of Bath

  • Ben Choy, Project Administrator, University of Bath

  • Dr Adriaan Taljaard, Marketing and Communication Lead, University of Bath

Get in touch

Media enquiries

Dr Adriaan Taljaard, Marketing and Communication Lead, Local Health and Global Profits, Department of Health, University of Bath. alt87@bath.ac.uk

Research enquiries or interest in participation

Contact LHGP@bath.ac.uk